Research output per year
Research output per year
Personal profile
Expertises
Neurooncology; Neuroscience; Brain development
Main research areas
YKL-40 in the human brain, with special focus on gliomas and brain development; treatment and monitoring of gliomas; gliogenesis in developing human brain.
Current research
Exploring the role of YKL-40 as a biomarker and treatment target in gliomas and the general function of YKL-40 in adult and developing human brain.
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Camilla Bjørnbak Holst is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Perspective: targeting VEGF-A and YKL-40 in glioblastoma - matter matters
Holst, C. B., Pedersen, H., Obara, E. A. A., Vitting-Seerup, K., Jensen, K. E., Skjøth-Rasmussen, J., Lund, E. L., Poulsen, H. S., Johansen, J. S. & Hamerlik, P., 3 Apr 2021, In: Cell cycle (Georgetown, Tex.). 20, 7, p. 702-715 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
4 Citations (Scopus) -
Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
Holst, C. B., Christensen, I. J., Vitting-Seerup, K., Skjøth-Rasmussen, J., Hamerlik, P., Poulsen, H. S. & Johansen, J. S., 1 Jan 2021, In: Neuro-Oncology Advances. 3, 1, p. 1-11 11 p., vdab072.Research output: Contribution to journal › Journal article › Research › peer-review
3 Citations (Scopus) -
YKL-40 angiogenesis and immune modulation in glioblastoma
Holst, C. B., 2021Research output: Book/Report › Ph.D. thesis
-
Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
Holst, C. B., Christensen, I. J., Skjøth-Rasmussen, J., Hamerlik, P., Poulsen, H. S. & Johansen, J. S., 17 Apr 2020, In: Frontiers in Oncology. 10, 478.Research output: Contribution to journal › Journal article › Research › peer-review
6 Citations (Scopus) -
Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors
Johansen, M. D., Urup, T., Holst, C. B., Christensen, I. J., Grunnet, K., Lassen, U., Friis, S. & Poulsen, H. S., 2018, In: Cancer Investigation. 36, 9-10, p. 512-519 8 p.Research output: Contribution to journal › Journal article › Research › peer-review